Brains Bioceutical Corp. завершило привлечение капитала на сумму 31,9 миллиона долларов США с ведущим инвестором DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
ВАНКУВЕР, Британская Колумбия, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. («Brains” or the “Company») рада объявить о завершении привлечения капитала в размере 31,9 млн долларов США...
Brains Bioceutical Corp. completa un'operazione di aumento di capitale da 31,9 milioni di dollari con l'investitore principale, DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (qui di seguito "Brains" o la "Società") è lieta di annunciare il completamento dell'operazione di aumento di...
Brains Bioceutical Corp. rondt een kapitaalverhoging van USD $31,9 miljoen af met lead investor DSM Venturing
June 17, 2021 16:51 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. ("Brains" of het "Bedrijf") is verheugd de voltooiing te kunnen aankondigen van een kapitaalverhoging van USD...
Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing
June 16, 2021 02:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (“Brains” or the “Company”) is pleased to announce the completion of a USD $31.9 million capital raise with...